Francesca Biondo

803 total citations
18 papers, 196 citations indexed

About

Francesca Biondo is a scholar working on Hematology, Genetics and Genetics. According to data from OpenAlex, Francesca Biondo has authored 18 papers receiving a total of 196 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 7 papers in Genetics and 4 papers in Genetics. Recurrent topics in Francesca Biondo's work include Chronic Lymphocytic Leukemia Research (5 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Hemophilia Treatment and Research (4 papers). Francesca Biondo is often cited by papers focused on Chronic Lymphocytic Leukemia Research (5 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Hemophilia Treatment and Research (4 papers). Francesca Biondo collaborates with scholars based in Italy, United Kingdom and Türkiye. Francesca Biondo's co-authors include Massimo Breccia, Giuliana Alimena, Eleonora Russo, Roberto Latagliata, Megan Pritchard, Christoph Mueller, Amelia Jewell, James H. Cole, Claire J. Steves and Marco Mancini and has published in prestigious journals such as Blood, Cancer and Journal of Thrombosis and Haemostasis.

In The Last Decade

Francesca Biondo

17 papers receiving 191 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francesca Biondo Italy 8 146 75 37 24 17 18 196
Ahmed El Awwa Qatar 6 89 0.6× 107 1.4× 16 0.4× 3 0.1× 3 0.2× 8 275
Erin O’Ferrall Canada 11 32 0.2× 38 0.5× 108 2.9× 3 0.1× 8 0.5× 27 274
Joseph C. Torkildson United States 6 64 0.4× 120 1.6× 8 0.2× 2 0.1× 15 0.9× 16 265
Seema Hashmi Pakistan 9 13 0.1× 23 0.3× 11 0.3× 9 0.4× 12 0.7× 33 204
Jill R. Schofield United States 11 45 0.3× 26 0.3× 52 1.4× 1 0.0× 16 0.9× 14 199
Yaser Al Malik Saudi Arabia 9 16 0.1× 21 0.3× 28 0.8× 3 0.1× 15 0.9× 33 200
J. Howard Jaster United States 6 20 0.1× 8 0.1× 20 0.5× 9 0.4× 8 0.5× 21 185
Jennifer Mosebach Germany 6 122 0.8× 13 0.2× 3 0.1× 7 0.3× 11 0.6× 9 179
István Szanyi Hungary 11 10 0.1× 29 0.4× 7 0.2× 20 0.8× 14 0.8× 36 319
Sara Napolitano Italy 6 61 0.4× 47 0.6× 4 0.1× 3 0.1× 14 0.8× 12 195

Countries citing papers authored by Francesca Biondo

Since Specialization
Citations

This map shows the geographic impact of Francesca Biondo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Biondo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Biondo more than expected).

Fields of papers citing papers by Francesca Biondo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesca Biondo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Biondo. The network helps show where Francesca Biondo may publish in the future.

Co-authorship network of co-authors of Francesca Biondo

This figure shows the co-authorship network connecting the top 25 collaborators of Francesca Biondo. A scholar is included among the top collaborators of Francesca Biondo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca Biondo. Francesca Biondo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Kavaklı, Kaan, Adam Cuker, Laurent Frenzel, et al.. (2025). Health-related quality of life in adults with hemophilia B after gene therapy with fidanacogene elaparvovec: results from the BENEGENE-2 trial. Journal of Thrombosis and Haemostasis. 24(1). 132–145.
2.
Leavitt, Andrew D., Kaan Kavaklı, Laurent Frenzel, et al.. (2024). Efficacy and Safety of Giroctocogene Fitelparvovec in Adults with Moderately Severe to Severe Hemophilia Α: Primary Analysis Results from the Phase 3 ΑFFINE Gene Therapy Trial. Blood. 144(Supplement 1). 1053–1053. 2 indexed citations
3.
Frenzel, Laurent, Kaan Kavaklı, Robert Klamroth, et al.. (2023). Characterizing a Cohort of Patients with Hemophilia B Treated with Fidanacogene Elaparvovec from the Phase 3 Benegene-2 Study Who Returned to Factor IX Prophylaxis. Blood. 142(Supplement 1). 2257–2257. 2 indexed citations
4.
Biondo, Francesca, et al.. (2023). Risks and limits of bariatric surgery: old solutions and a new potential option.. PubMed. 27(12). 5831–5840. 1 indexed citations
5.
Bruchhage, Muriel, Hans‐Georg Müller, Maximilian Pietsch, et al.. (2023). Longitudinal Brain and Cognitive Development of the First 1000 Days:A Large Multi-Cohort Multi-Scanner Study. Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition. 1 indexed citations
6.
Biondo, Francesca, Amelia Jewell, Megan Pritchard, et al.. (2022). Brain-age is associated with progression to dementia in memory clinic patients. NeuroImage Clinical. 36. 103175–103175. 37 indexed citations
7.
Wu, Hsuan‐Chen, et al.. (2020). Mentalising and conversation-following in autism. Autism. 24(8). 1980–1994. 1 indexed citations
8.
Biondo, Francesca, Amelia Jewell, Megan Pritchard, et al.. (2020). Brain‐age predicts subsequent dementia in memory clinic patients. Alzheimer s & Dementia. 16(S5). 6 indexed citations
9.
Santoro, Cristina, Francesca Biondo, Erminia Baldacci, et al.. (2013). Rituximab in Previously Treated Primary Immune Thrombocytopenia Patients: Evaluation of Short- and Long-Term Efficacy and Safety. Acta Haematologica. 132(1). 24–29. 3 indexed citations
10.
Santoro, Cristina, Angela Rago, Francesca Biondo, et al.. (2010). Prevalence of allo‐immunization anti‐HLA and anti‐integrin αIIbβ3 in Glanzmann Thromboasthenia patients. Haemophilia. 16(5). 805–812. 38 indexed citations
11.
Latagliata, Roberto, Angela Rago, Antonio Spadea, et al.. (2009). Decisional flow with a scoring system to start platelet-lowering treatment in patients with essential thrombocythemia: long-term results. International Journal of Hematology. 90(4). 486–491. 1 indexed citations
12.
13.
Alimena, Giuliana, Massimo Breccia, Roberto Latagliata, et al.. (2006). Sudden blast crisis in patients with Philadelphia chromosome‐positive chronic myeloid leukemia who achieved complete cytogenetic remission after imatinib therapy. Cancer. 107(5). 1008–1013. 18 indexed citations
14.
15.
Breccia, Massimo, Ida Carmosino, Francesca Biondo, et al.. (2005). Usefulness and prognostic impact on survival of WHO reclassification in FAB low risk myelodyplastic syndromes. Leukemia Research. 30(2). 178–182. 13 indexed citations
16.
Breccia, Massimo, Andrea Mengarelli, Marco Mancini, et al.. (2005). Myelodysplastic syndromes in patients under 50 years old: a single institution experience. Leukemia Research. 29(7). 749–754. 17 indexed citations
17.
Latagliata, Roberto, Massimo Breccia, Ida Carmosino, et al.. (2004). Association of Hydroxyurea to Imatinib Is Effective in Patients with Chronic Myelogenous Leukemia Resistant to Imatinib Alone.. Blood. 104(11). 4693–4693. 1 indexed citations
18.
Latagliata, Roberto, Massimo Breccia, Ida Carmosino, et al.. (2004). Elderly patients with Ph+ chronic myelogenous leukemia (CML): results of imatinib mesylate treatment. Leukemia Research. 29(3). 287–291. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ahmed El Awwa Breakdown of academic impact, for papers by Erin O’Ferrall Breakdown of academic impact, for papers by Joseph C. Torkildson Breakdown of academic impact, for papers by Seema Hashmi Breakdown of academic impact, for papers by Jill R. Schofield Breakdown of academic impact, for papers by Yaser Al Malik Breakdown of academic impact, for papers by J. Howard Jaster Breakdown of academic impact, for papers by Jennifer Mosebach Breakdown of academic impact, for papers by István Szanyi Breakdown of academic impact, for papers by Sara Napolitano
Rankless by CCL
2026